MAPK3 and cancer: Dysfunctional STAT1 may contribute to cancer development and progression, while at the same time the ERK1/2 pathway regulates a common set of cell death regulators such as BCL-2, BCL-XL and BIM, indicating that it plays a role in cell cycle control [39]–[41].